Q3 FY2026 · ended Sep 30, 2026 · Revenue $352.65M, +3.7% YoY · Filed Nov 3, 2026
Curaleaf Holdings, Inc. (CURLF) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $352.6 million and a net loss of $32.7 million. Free cash flow was $4.0 million. As of Sep 30, 2026 it held $92.4 million in cash and investments and $928.5 million in total debt.
Revenue
$352.65M
+3.7% vs prior quarter
Net income
$-32.72M
-361.6% vs prior quarter
Operating cash flow
$21.10M
-58.0% vs prior quarter
Free cash flow
$4.03M
-76.7% vs prior quarter
EPS
$-0.12
-340.0% vs prior quarter
Dividend per share
None
Shares outstanding
264.98M
+0.1% vs prior quarter
Net cash
$-836.09M
Q3 FY2026
Operating margin
0.8%
Q3 FY2026
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CURLF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Stamford, CT
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1756770
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
- Aurora Cannabis Inc ACB
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
|---|---|---|
| Revenue | $352.6M | $340.1M |
| Operating income | $2.9M | $4.2M |
| Net income | -$32.7M | $12.5M |
| Diluted EPS | -$0.12 | $0.05 |
| Operating cash flow | $21.1M | $50.2M |
| Free cash flow | $4.0M | $17.3M |
| Total assets | $2.8B | $2.8B |
| Total liabilities | $1.9B | $1.9B |
| Stockholders' equity | $847.0M | $867.5M |
| Cash and investments | $92.4M | $94.6M |
| Total debt | $928.5M | $909.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Other events
|
Oct 28, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Other events
|
Oct 19, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Other events
|
Oct 6, 2026 | Oct 6, 2026 |
All 226 Curaleaf Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.